AstraZeneca– tag –
-
Daiichi Sankyo and AstraZeneca’s Gastric Cancer ADC Receives Positive EMA CHMP Opinion for Approval
European Medicines Agency (EMA) Europe Overview The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending approval for an antibody-drug conjugate (ADC) develo... -
Daiichi Sankyo Unveils Extensive Oncology Portfolio Progress at ASCO; Datopotamab Deruxtecan Approved for First-Line mTNBC
Daiichi Sankyo (Press Release), MedCity News, ADC Review, FirstWord Pharma Japan Overview Daiichi Sankyo will present over 25 abstracts at the 2026 ASCO Annual Meeting, showcasing its leading oncology portfolio, including new clinical da... -
Immunai and AstraZeneca Expand Oncology AI Partnership for Third Time, Valued at Up To $37.5 Million
WTWH Media USA Overview Immunai, a startup building foundation models for the human immune system, has announced a third expansion of its oncology partnership with AstraZeneca, entitling Immunai to up to $37.5 million through 2027. This ...
12